- Home
- ZSTK vs PULM Comparison
ZSTK vs PULM Comparison
Compare ZSTK & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZSTK | PULM |
|---|---|---|
| Founded | 2019 | 2003 |
| Country | Canada | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 9.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ZSTK | PULM |
|---|---|---|
| Price | $4.01 | $1.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.4K | 16.1K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,910,000.00 |
| Revenue This Year | $15.73 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5069.93 |
| 52 Week Low | $3.72 | $1.16 |
| 52 Week High | $11.00 | $9.37 |
Technical Indicators
Market Signals| Indicator | ZSTK | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 50.04 |
| Support Level | $3.72 | $1.20 |
| Resistance Level | $5.86 | $1.43 |
| Average True Range (ATR) | 0.75 | 0.06 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 29.44 | 65.77 |
Price Performance
Historical ComparisonAbout ZSTK ZeroStack Corp. Common Stock
ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).